sandostatine 100 µg/1 ml inj. sol. s.c./i.v. amp.
novartis pharma sa-nv - octreotide 0,1 mg - solution for injection - 100 microgram/1 ml - octreotide 0.1 mg - octreotide
sandostatine 500 µg/1 ml inj. sol. s.c./i.v. amp.
novartis pharma sa-nv - octreotide 0,5 mg - solution for injection - 500 microgram/1 ml - octreotide 0.5 mg - octreotide
sandostatine long acting repeatable 30 mg inj. susp. (pwdr. + solv.) i.m. pre-filled syr. vial
novartis pharma sa-nv - octreotide acetate 33,6 mg - eq. octreotide 30 mg - powder and solvent for suspension for injection - 30 mg - octreotide acetate 33.6 mg - octreotide
sandostatine long acting repeatable 10 mg inj. susp. (pwdr. + solv.) i.m. pre-filled syr. vial
novartis pharma sa-nv - octreotide acetate 11,2 mg - eq. octreotide 10 mg - powder and solvent for suspension for injection - 10 mg - octreotide acetate 11.2 mg - octreotide
sandostatine long acting repeatable 20 mg inj. susp. (pwdr. + solv.) i.m. pre-filled syr. vial
novartis pharma sa-nv - octreotide acetate 22,4 mg - eq. octreotide 20 mg - powder and solvent for suspension for injection - 20 mg - octreotide acetate 22.4 mg - octreotide
sandostatine 0,1 mg/ml solution for injection
impexeco - octreotide - solution for injection - 0,1 mg/ml - octreotide 0.1 mg/ml - octreotide
sandostatine 0.5 mg/ml solution for injection
impexeco - octreotide - solution for injection - 0.5 mg/ml - octreotide 0.5 mg/ml - octreotide
sandostatine 0,1 mg/ml (impexeco) inj. sol. i.v./s.c. amp.
impexeco sa-nv - octreotide 0,1 mg/ml - solution for injection - octreotide
sandostatine 0.5 mg/ml (impexeco) inj. sol. i.v./s.c. amp.
impexeco sa-nv - octreotide 0,5 mg/ml - solution for injection - octreotide
sandostatine long acting repeatable 20 mg (abacus medicine) inj. susp. (pwdr. + solv.) i.m. pre-filled syr. vial
abacus medicine a.s. - octreotide acetate 22,4 mg - eq. octreotide 20 mg - powder and solvent for suspension for injection - octreotide